Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models

Kazuo Umezawa, Itaru Kojima, Siro Simizu, Yinzhi Lin, Hitomi Fukatsu, Naoki Koide, Yukiomi Nakade, Masashi Yoneda

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Increasing metabolic syndromes including type-2 diabetes mellitus, obesity, and steatohepatitis are serious problems in most countries in the world. Neurodegenerative diseases such as Alzheimer, Parkinson’s, and Huntington’s diseases are increasing in many countries. However, therapy for these diseases is not sufficient yet. Thus, effective chemotherapy for these diseases is being expected. Conophylline is an alkaloid isolated from the leaves of Ervatamia microphylla and related plants. It was found to induce beta-cell differentiation in the precursor pancreatic cells. Oral administration of this compound ameliorated type-2 diabetes mellitus model in mice and rats. Later, fibrosis of the pancreatic islets was found to be greatly reduced by conophylline in the pancreatic islets. It also inhibited chemically induced liver cirrhosis. Further study indicated that conophylline inhibited non-alcoholic steatohepatitis in the model mice. On the one hand, loss of autophagy often causes protein aggregation to give neural cell death. Conophylline was found to activate autophagy in cultured neural cells. Activation of autophagy ameliorated cellular models of Parkinson’s and Huntington’s diseases. Thus, conophylline is likely to be useful for the development of chemotherapy for metabolic and neurodegenerative diseases.

Original languageEnglish
Pages (from-to)1-7
Number of pages7
JournalHuman Cell
DOIs
Publication statusAccepted/In press - 2017 Dec 16

Fingerprint

Metabolic Diseases
Alkaloids
Neurodegenerative Diseases
Autophagy
Huntington Disease
Fatty Liver
Islets of Langerhans
Type 2 Diabetes Mellitus
Parkinson Disease
Therapeutics
Drug Therapy
Liver Cirrhosis
Oral Administration
Cell Differentiation
Cultured Cells
Alzheimer Disease
Fibrosis
Cell Death
Obesity
conophylline

Keywords

  • Conophylline
  • Diabetes mellitus
  • Fibrosis
  • Non-alcoholic steatohepatitis (NASH)
  • Parkinson’s disease

ASJC Scopus subject areas

  • Cell Biology
  • Cancer Research

Cite this

Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models. / Umezawa, Kazuo; Kojima, Itaru; Simizu, Siro; Lin, Yinzhi; Fukatsu, Hitomi; Koide, Naoki; Nakade, Yukiomi; Yoneda, Masashi.

In: Human Cell, 16.12.2017, p. 1-7.

Research output: Contribution to journalArticle

Umezawa, Kazuo ; Kojima, Itaru ; Simizu, Siro ; Lin, Yinzhi ; Fukatsu, Hitomi ; Koide, Naoki ; Nakade, Yukiomi ; Yoneda, Masashi. / Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models. In: Human Cell. 2017 ; pp. 1-7.
@article{7a34459108764bd3a71b6989d518cf06,
title = "Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models",
abstract = "Increasing metabolic syndromes including type-2 diabetes mellitus, obesity, and steatohepatitis are serious problems in most countries in the world. Neurodegenerative diseases such as Alzheimer, Parkinson’s, and Huntington’s diseases are increasing in many countries. However, therapy for these diseases is not sufficient yet. Thus, effective chemotherapy for these diseases is being expected. Conophylline is an alkaloid isolated from the leaves of Ervatamia microphylla and related plants. It was found to induce beta-cell differentiation in the precursor pancreatic cells. Oral administration of this compound ameliorated type-2 diabetes mellitus model in mice and rats. Later, fibrosis of the pancreatic islets was found to be greatly reduced by conophylline in the pancreatic islets. It also inhibited chemically induced liver cirrhosis. Further study indicated that conophylline inhibited non-alcoholic steatohepatitis in the model mice. On the one hand, loss of autophagy often causes protein aggregation to give neural cell death. Conophylline was found to activate autophagy in cultured neural cells. Activation of autophagy ameliorated cellular models of Parkinson’s and Huntington’s diseases. Thus, conophylline is likely to be useful for the development of chemotherapy for metabolic and neurodegenerative diseases.",
keywords = "Conophylline, Diabetes mellitus, Fibrosis, Non-alcoholic steatohepatitis (NASH), Parkinson’s disease",
author = "Kazuo Umezawa and Itaru Kojima and Siro Simizu and Yinzhi Lin and Hitomi Fukatsu and Naoki Koide and Yukiomi Nakade and Masashi Yoneda",
year = "2017",
month = "12",
day = "16",
doi = "10.1007/s13577-017-0196-4",
language = "English",
pages = "1--7",
journal = "Human Cell",
issn = "0914-7470",
publisher = "Springer Heidelberg",

}

TY - JOUR

T1 - Therapeutic activity of plant-derived alkaloid conophylline on metabolic syndrome and neurodegenerative disease models

AU - Umezawa, Kazuo

AU - Kojima, Itaru

AU - Simizu, Siro

AU - Lin, Yinzhi

AU - Fukatsu, Hitomi

AU - Koide, Naoki

AU - Nakade, Yukiomi

AU - Yoneda, Masashi

PY - 2017/12/16

Y1 - 2017/12/16

N2 - Increasing metabolic syndromes including type-2 diabetes mellitus, obesity, and steatohepatitis are serious problems in most countries in the world. Neurodegenerative diseases such as Alzheimer, Parkinson’s, and Huntington’s diseases are increasing in many countries. However, therapy for these diseases is not sufficient yet. Thus, effective chemotherapy for these diseases is being expected. Conophylline is an alkaloid isolated from the leaves of Ervatamia microphylla and related plants. It was found to induce beta-cell differentiation in the precursor pancreatic cells. Oral administration of this compound ameliorated type-2 diabetes mellitus model in mice and rats. Later, fibrosis of the pancreatic islets was found to be greatly reduced by conophylline in the pancreatic islets. It also inhibited chemically induced liver cirrhosis. Further study indicated that conophylline inhibited non-alcoholic steatohepatitis in the model mice. On the one hand, loss of autophagy often causes protein aggregation to give neural cell death. Conophylline was found to activate autophagy in cultured neural cells. Activation of autophagy ameliorated cellular models of Parkinson’s and Huntington’s diseases. Thus, conophylline is likely to be useful for the development of chemotherapy for metabolic and neurodegenerative diseases.

AB - Increasing metabolic syndromes including type-2 diabetes mellitus, obesity, and steatohepatitis are serious problems in most countries in the world. Neurodegenerative diseases such as Alzheimer, Parkinson’s, and Huntington’s diseases are increasing in many countries. However, therapy for these diseases is not sufficient yet. Thus, effective chemotherapy for these diseases is being expected. Conophylline is an alkaloid isolated from the leaves of Ervatamia microphylla and related plants. It was found to induce beta-cell differentiation in the precursor pancreatic cells. Oral administration of this compound ameliorated type-2 diabetes mellitus model in mice and rats. Later, fibrosis of the pancreatic islets was found to be greatly reduced by conophylline in the pancreatic islets. It also inhibited chemically induced liver cirrhosis. Further study indicated that conophylline inhibited non-alcoholic steatohepatitis in the model mice. On the one hand, loss of autophagy often causes protein aggregation to give neural cell death. Conophylline was found to activate autophagy in cultured neural cells. Activation of autophagy ameliorated cellular models of Parkinson’s and Huntington’s diseases. Thus, conophylline is likely to be useful for the development of chemotherapy for metabolic and neurodegenerative diseases.

KW - Conophylline

KW - Diabetes mellitus

KW - Fibrosis

KW - Non-alcoholic steatohepatitis (NASH)

KW - Parkinson’s disease

UR - http://www.scopus.com/inward/record.url?scp=85038093170&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85038093170&partnerID=8YFLogxK

U2 - 10.1007/s13577-017-0196-4

DO - 10.1007/s13577-017-0196-4

M3 - Article

SP - 1

EP - 7

JO - Human Cell

JF - Human Cell

SN - 0914-7470

ER -